Repligen Corp. (RGEN)

143.66 +1.48 (+1.04%) USD  |  NASDAQ  |  Feb 09, 16:00
143.66 0.00 (0.00%) After-Hours: 19:53
More

Repligen Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Enovis Corp. Upgrade
Abbott Laboratories Upgrade
Accuray, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade